Microcoat now offering Assay Development and Sample Measurement on MSD® Platform

Microcoat expands its technological portfolio by Meso Scale Discovery´s Electrochemiluminescence (MSD-ECL) platform. Based on non-radioactive electrochemiluminescent labels for ultra-sensitive detection, MSD yields higher sensitivity and broader dynamic range compared to ELISA technology. Microcoat offers development of assays from the scratch as well as transfer of classical ELISA formats in addition to method comparison, validation and sample measurement.  Customers profit from our year-long experience in custom-fit optimization and manufacturing of antibody conjugates including MSD´s SULFO-Tag®.

MORE NEWS
  • 23Mrz

    Microcoat ist dabei! Ausbildungskampagne #Könnenlernen

    Read More →
  • 09Mrz

    Microcoat announces the 8th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 09Feb

    Der Abschlussjahrgang des Ausbildungsberufes „Agrartechnischer Assistent“ aus Landsberg besucht die Firma „Microcoat“

    Read More →
  • 09Feb

    Monocyte Activation Test (MAT) Munich/Bernried, GERMANY

    Read More →
  • 09Feb

    Low Endotoxin Recovery/Masking Training Course Munich/Bernried, GERMANY

    Read More →
  • 19Dez

    Merry Christmas!

    Read More →
  • 15Dez

    MAT-Santa has an early Christmas present for you!

    Read More →
  • 03Nov

    Microcoat announces the 7th Monocyte-Activation Test Proficiency Test Program

    Read More →
  • 17Okt

    Meet us at the PharmaLab 2022 Düsseldorf/Neuss, Germany

    Read More →
  • 10Okt

    Microcoat announces agreement with Olink to offer innovative proteomic approaches with Olink® Proximity Extension Assay (PEA) technology for pharma partners

    Read More →